PL208757A1 - Sposob wytwarzania pochodnych izochinoliny - Google Patents

Sposob wytwarzania pochodnych izochinoliny

Info

Publication number
PL208757A1
PL208757A1 PL20875778A PL20875778A PL208757A1 PL 208757 A1 PL208757 A1 PL 208757A1 PL 20875778 A PL20875778 A PL 20875778A PL 20875778 A PL20875778 A PL 20875778A PL 208757 A1 PL208757 A1 PL 208757A1
Authority
PL
Poland
Prior art keywords
making
isochinoline derivatives
isochinoline
derivatives
making isochinoline
Prior art date
Application number
PL20875778A
Other languages
English (en)
Other versions
PL121492B1 (en
Inventor
Jdm J Sararese
Richard J Kitz
Sara Ginsburg
Original Assignee
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Gen Hospital filed Critical Massachusetts Gen Hospital
Publication of PL208757A1 publication Critical patent/PL208757A1/pl
Publication of PL121492B1 publication Critical patent/PL121492B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL1978208757A 1977-08-01 1978-07-31 Process for preparing novel salts of bis-tetrahydroisoquinolinium-alkyl m-or p-phenylene-dialkanocarboxylatessilanov bis-tetragidroizokhinolino-alkilovykh solejj PL121492B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82079477A 1977-08-01 1977-08-01

Publications (2)

Publication Number Publication Date
PL208757A1 true PL208757A1 (pl) 1979-06-04
PL121492B1 PL121492B1 (en) 1982-05-31

Family

ID=25231743

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978208757A PL121492B1 (en) 1977-08-01 1978-07-31 Process for preparing novel salts of bis-tetrahydroisoquinolinium-alkyl m-or p-phenylene-dialkanocarboxylatessilanov bis-tetragidroizokhinolino-alkilovykh solejj

Country Status (21)

Country Link
JP (1) JPS5455577A (pl)
AT (1) AT368496B (pl)
AU (1) AU523706B2 (pl)
BE (1) BE869415A (pl)
CA (1) CA1113096A (pl)
DD (1) DD143254A5 (pl)
DE (1) DE2833505A1 (pl)
DK (1) DK339078A (pl)
ES (1) ES472229A1 (pl)
FI (1) FI782363A7 (pl)
FR (1) FR2399429A1 (pl)
GB (1) GB2002758B (pl)
IE (1) IE47014B1 (pl)
IL (1) IL55254A (pl)
LU (1) LU80062A1 (pl)
MC (1) MC1197A1 (pl)
NL (1) NL7808067A (pl)
PL (1) PL121492B1 (pl)
SE (1) SE7808267L (pl)
SU (1) SU862820A3 (pl)
ZA (1) ZA784331B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4235906A (en) 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
JPS5645459A (en) * 1979-09-20 1981-04-25 Otsuka Pharmaceut Co Ltd Cyclic amine
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
JPH0555438A (ja) * 1991-08-26 1993-03-05 Rohm Co Ltd 電子部品のリード端子構造
ATE295351T1 (de) * 1997-03-25 2005-05-15 Avera Pharmaceuticals Inc Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
AU2007328210B2 (en) * 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
WO2011022491A1 (en) 2009-08-19 2011-02-24 Cornell University Cysteine for physiological injection
CN114057642B (zh) * 2021-12-10 2023-03-28 广东嘉博制药有限公司 一种米库氯铵中间体的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5156762U (pl) * 1974-10-28 1976-05-04

Also Published As

Publication number Publication date
ATA555478A (de) 1982-02-15
GB2002758B (en) 1982-02-03
IL55254A0 (en) 1978-09-29
CA1113096A (en) 1981-11-24
MC1197A1 (fr) 1979-03-19
PL121492B1 (en) 1982-05-31
AT368496B (de) 1982-10-11
ZA784331B (en) 1979-12-27
AU3847678A (en) 1980-02-07
IE47014B1 (en) 1983-11-30
DE2833505A1 (de) 1979-04-05
FR2399429A1 (fr) 1979-03-02
BE869415A (fr) 1979-01-31
GB2002758A (en) 1979-02-28
ES472229A1 (es) 1979-03-16
DD143254A5 (de) 1980-08-13
IE781550L (en) 1979-02-01
DK339078A (da) 1979-02-02
SU862820A3 (ru) 1981-09-07
IL55254A (en) 1983-03-31
FI782363A7 (fi) 1979-02-02
JPS5455577A (en) 1979-05-02
AU523706B2 (en) 1982-08-12
LU80062A1 (fr) 1979-05-15
SE7808267L (sv) 1979-02-02
NL7808067A (nl) 1979-02-05
FR2399429B1 (pl) 1981-07-17

Similar Documents

Publication Publication Date Title
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL204549A1 (pl) Sposob wytwarzania pochodnych pirolidyny
PL211492A1 (pl) Sposob wytwarzania nowych glikozydowych pochodnych pleuromutyliny
PL204550A1 (pl) Sposob wytwarzania pochodnych pirolidyny
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL208757A1 (pl) Sposob wytwarzania pochodnych izochinoliny
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL208436A1 (pl) Sposob wytwarzania pochodnych bis-(nitrozoureido)-polioli
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL215005A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL208406A1 (pl) Sposob wytwarzania pochodnych furokumaryny
PL204882A1 (pl) Sposob wytwarzania nowych triazolo-tieno-dwuazepinonow-1